These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1068 related articles for article (PubMed ID: 7573367)

  • 1. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
    Carbone A; Gloghini A; Gruss HJ; Pinto A
    Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
    Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
    Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
    Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
    Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.
    Xerri L; Chetaille B; Serriari N; Attias C; Guillaume Y; Arnoulet C; Olive D
    Hum Pathol; 2008 Jul; 39(7):1050-8. PubMed ID: 18479731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation.
    Felgar RE; Macon WR; Kinney MC; Roberts S; Pasha T; Salhany KE
    Am J Pathol; 1997 Jun; 150(6):1893-900. PubMed ID: 9176382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
    Nguyen PL; Harris NL; Ritz J; Robertson MJ
    Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic markers in non-Hodgkin's lymphoma.
    Freedman AS; Nadler LM
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of current and new discriminating markers in the immunodiagnosis of Hodgkin's disease and other phenotypically related lymphomas.
    Carbone A; Gloghini A
    Pathologica; 1996 Jun; 88(3):169-74. PubMed ID: 8916443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 expression in Hodgkin's disease.
    O'Grady JT; Stewart S; Lowrey J; Howie SE; Krajewski AS
    Am J Pathol; 1994 Jan; 144(1):21-6. PubMed ID: 7507299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non-Hodgkin's lymphomas/leukemias.
    Carbone A; Gloghini A; Zagonel V; Aldinucci D; Gattei V; Degan M; Improta S; Sorio R; Monfardini S; Pinto A
    Blood; 1995 Dec; 86(12):4617-26. PubMed ID: 8541553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
    Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
    Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
    Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
    J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
    Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
    Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of enolases in T cell tumors and Hodgkin's disease.
    Oka K; Mori N; Haimoto H; Kato K
    Lab Invest; 1990 Dec; 63(6):792-7. PubMed ID: 2255187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
    Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
    Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas.
    Drillenburg P; van der Voort R; Koopman G; Dragosics B; van Krieken JH; Kluin P; Meenan J; Lazarovits AI; Radaszkiewicz T; Pals ST
    Am J Pathol; 1997 Mar; 150(3):919-27. PubMed ID: 9060830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines.
    Carbone A; Gloghini A; Gattei V; Aldinucci D; Degan M; De Paoli P; Zagonel V; Pinto A
    Blood; 1995 Feb; 85(3):780-9. PubMed ID: 7530508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of thymus and activation regulated chemokine and its receptor CCR4 in nodal and cutaneous anaplastic large-cell lymphomas and Hodgkin's disease.
    Vermeer MH; Dukers DF; ten Berge RL; Bloemena E; Wu L; Vos W; de Vries E; Tensen CP; Meijer CJ; Willemze R
    Mod Pathol; 2002 Aug; 15(8):838-44. PubMed ID: 12181269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.